Search Results - "on behalf of the J’xactly Investigators"

A Multicenter Prospective Observational Cohort Study to Investigate the Effectiveness and Safety of Rivaroxaban in Japanese Venous Thromboembolism Patients (The J’xactly Study) by Okumura, Yasuo, Fukuda, Ikuo, Nakamura, Mashio, Yamada, Norikazu, Takayama, Morimasa, Maeda, Hideaki, Yamashita, Takeshi, Ikeda, Takanori, Mo, Makoto, Kobayashi, Takao, Niwa, Akihiro, Matsuo, Hiroshi, Yokoi, Hiroyoshi, Koga, Masatoshi, Yamazaki, Tsutomu, Hirayama, Atsushi, on behalf of the J’xactly Investigators

“…Background:There is insufficient real-world data on the current status of Japanese patients with venous thromboembolism (VTE) or its treatment and prevention…”
Get full text

CORRIGENDUM: A Multicenter Prospective Observational Cohort Study to Investigate the Effectiveness and Safety of Rivaroxaban in Japanese Venous Thromboembolism Patients (The J’xactly Study) by Okumura, Yasuo, Fukuda, Ikuo, Nakamura, Mashio, Yamada, Norikazu, Takayama, Morimasa, Maeda, Hideaki, Yamashita, Takeshi, Ikeda, Takanori, Mo, Makoto, Kobayashi, Takao, Niwa, Akihiro, Matsuo, Hiroshi, Yokoi, Hiroyoshi, Koga, Masatoshi, Yamazaki, Tsutomu, Hirayama, Atsushi, on behalf of the J’xactly Investigators

Get full text

A Multicenter Prospective Observational Cohort Study to Investigate the Effectiveness and Safety of Rivaroxaban in Japanese Venous Thromboembolism Patients (The J’xactly Study) by Okumura, Yasuo, Fukuda, Ikuo, Nakamura, Mashio, Yamada, Norikazu, Takayama, Morimasa, Maeda, Hideaki, Yamashita, Takeshi, Ikeda, Takanori, Mo, Makoto, Kobayashi, Takao, Niwa, Akihiro, Matsuo, Hiroshi, Yokoi, Hiroyoshi, Koga, Masatoshi, Yamazaki, Tsutomu, Hirayama, Atsushi, on behalf of the J’xactly Investigators

“…Background:There is insufficient real-world data on the current status of Japanese patients with venous thromboembolism (VTE) or its treatment and prevention…”
Get full text

Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J’xactly study by Migita, Shohei, Okumura, Yasuo, Fukuda, Ikuo, Nakamura, Mashio, Yamada, Norikazu, Takayama, Morimasa, Maeda, Hideaki, Yamashita, Takeshi, Ikeda, Takanori, Mo, Makoto, Yamazaki, Tsutomu, Hirayama, Atsushi

“…Background An established treatment strategy for asymptomatic pulmonary embolism (PE) or deep vein thrombosis (DVT) remains uncertain in Japan; therefore, in…”
Get full text

Clinical Outcome After Discontinuation of Anticoagulation Therapy in Japanese Patients With Venous Thromboembolism　― Insights From the J’xactly Study by Yamashita, Takeshi, Fukuda, Ikuo, Nakamura, Mashio, Yamada, Norikazu, Takayama, Morimasa, Maeda, Hideaki, Ikeda, Takanori, Mo, Makoto, Yamazaki, Tsutomu, Okumura, Yasuo, Hirayama, Atsushi, on behalf of the J’xactly Investigators

“…Background: Rivaroxaban, a direct oral anticoagulant, is used as first-line treatment to prevent venous thromboembolism (VTE), including deep vein thrombosis…”
Get full text

Rivaroxaban Treatment for Patients With Unprovoked or Provoked Venous Thromboembolism　― Subanalysis of the J’xactly Study by Hisatake, Shinji, Ikeda, Takanori, Fukuda, Ikuo, Nakamura, Mashio, Yamada, Norikazu, Takayama, Morimasa, Maeda, Hideaki, Yamashita, Takeshi, Mo, Makoto, Yamazaki, Tsutomu, Okumura, Yasuo, Hirayama, Atsushi, on behalf of the J’xactly Investigators

“…Background: The efficacy and safety of direct oral anticoagulants (DOACs) in patients with unprovoked venous thromboembolism (VTE) remain unclear.Methods and…”
Get full text

Duration of Initial Intensive Rivaroxaban Therapy for Patients With Venous Thromboembolism　― Subanalysis of the J’xactly Study by Nakamura, Mashio, Fukuda, Ikuo, Yamada, Norikazu, Takayama, Morimasa, Maeda, Hideaki, Yamashita, Takeshi, Ikeda, Takanori, Mo, Makoto, Yamazaki, Tsutomu, Okumura, Yasuo, Hirayama, Atsushi, on behalf of the J’xactly Investigators

“…Background: Rivaroxaban, a direct oral anticoagulant, is used as a first-line treatment to prevent venous thromboembolism (VTE), including deep vein thrombosis…”
Get full text

Rivaroxaban Treatment for Patients With Unprovoked or Provoked Venous Thromboembolism　― Subanalysis of the J’xactly Study by Hisatake, Shinji, Ikeda, Takanori, Fukuda, Ikuo, Nakamura, Mashio, Yamada, Norikazu, Takayama, Morimasa, Maeda, Hideaki, Yamashita, Takeshi, Mo, Makoto, Yamazaki, Tsutomu, Okumura, Yasuo, Hirayama, Atsushi, on behalf of the J’xactly Investigators

“…Background: The efficacy and safety of direct oral anticoagulants (DOACs) in patients with unprovoked venous thromboembolism (VTE) remain unclear.Methods and…”
Get full text

Clinical Outcome After Discontinuation of Anticoagulation Therapy in Japanese Patients With Venous Thromboembolism　― Insights From the J’xactly Study by Yamashita, Takeshi, Fukuda, Ikuo, Nakamura, Mashio, Yamada, Norikazu, Takayama, Morimasa, Maeda, Hideaki, Ikeda, Takanori, Mo, Makoto, Yamazaki, Tsutomu, Okumura, Yasuo, Hirayama, Atsushi, on behalf of the J’xactly Investigators

“…Background: Rivaroxaban, a direct oral anticoagulant, is used as first-line treatment to prevent venous thromboembolism (VTE), including deep vein thrombosis…”
Get full text